Drug
Levalbuterol
Levalbuterol: highest development phase Approved, developed by Sumitomo Pharma, Teva. 3 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Sumitomo Pharma, Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| LEVALBUTEROL HYDROCHLORIDE | Approved | |
| levalbuterol NCT00073840 | Phase 3 | Asthma |
| levalbuterol 90 mcg NCT01656811 | Phase 2 | Asthma |
Latest
No recent events.
Follow Levalbuterol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.